GDF15 and Glucose intolerance: Interestingly, the beneficial effects of the PPARβ/δ agonist GW501516 on glucose intolerance, FA oxidation, ER stress, inflammation, and AMPK activation in HFD-fed mice were abrogated by the injection of a GDF15-neutralizing antibody as well as in Gdf15-/- mice.